Skip to main
OFIX
OFIX logo

Orthofix International (OFIX) Stock Forecast & Price Target

Orthofix International (OFIX) Analyst Ratings

Based on 4 analyst ratings
Strong Buy
Strong Buy 75%
Buy 25%
Hold 0%
Sell 0%
Strong Sell 0%

Bulls say

Orthofix Medical Inc. has demonstrated robust growth in its global spine segment, achieving a 14.2% increase in fiscal year 2024 driven by distribution expansion and deeper penetration in existing accounts. The company is projected to see its adjusted EBITDA margin increase significantly from 8.4% in 2024 to 13.5% by 2027, reflecting improved operational efficiency and profitability. Additionally, with sustainable top-line growth rates expected in the mid-to-upper single digits and a transition to positive free cash flow generation by the second half of 2025, Orthofix is positioned favorably in the market.

Bears say

Orthofix Medical Inc. is projected to experience net interest expenses ranging from $19 million to $20 million in FY/25, indicating ongoing financial burdens that could hinder profitability. Additionally, while the company is expected to maintain its investment in research and development dollars, this spending may decrease as a percentage of revenue, raising concerns about future growth and innovation potential. Lastly, despite a favorable macroeconomic environment for the spine and orthopedics market, the stock is trading near its 52-week lows, suggesting investor skepticism about the company's immediate outlook and performance.

Orthofix International (OFIX) has been analyzed by 4 analysts, with a consensus rating of Strong Buy. 75% of analysts recommend a Strong Buy, 25% recommend Buy, 0% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Orthofix International and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Orthofix International (OFIX) Forecast

Analysts have given Orthofix International (OFIX) a Strong Buy based on their latest research and market trends.

According to 4 analysts, Orthofix International (OFIX) has a Strong Buy consensus rating as of Oct 14, 2025. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $21.75, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $21.75, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Orthofix International (OFIX)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.